Mar 18, 2025
1:50
For every 50 shares held, investors received 1. The price per share adjusted from $0.02 to $0.00.
The split itself did not change the total investment value.
Hepion Pharmaceuticals, Inc. (HEPA) trades on the Other OTC in the Biotechnology industry.
Hepion Pharmaceuticals, Inc. company overviewThe latest split shown was on March 18, 2025. It was a 1-for-50 reverse split, so shareholders received 1 share for every 50 they held.
This history records 4 reverse splits between May 29, 2018 and March 18, 2025.